Warren D. Cooper

Partner & Chief Medical Officer at Healthcare Royalty Management LLC

Warren D. Cooper

Warren D. Cooper

Partner & Chief Medical Officer at Healthcare Royalty Management LLC

Overview
Career Highlights

Astra Merck, Inc.
Merck Research Laboratories
Merck & Co., Inc.

RelSci Relationships

2482

Number of Boards

6

Birthday

1953

Age

66

Relationships
RelSci Relationships are individuals Warren D. Cooper likely has professional access to. A relationship does not necessarily indicate a personal connection.

President at Frank M. Armstrong Consulting Ltd.

Relationship likelihood: Strong

Founder at Healthcare Royalty Management LLC

Relationship likelihood: Strong

Founder at Nuron Biotech, Inc.

Relationship likelihood: Strong

Founder at Healthcare Royalty Management LLC

Relationship likelihood: Strong

Chairman of the Board & Chief Executive Officer at Zynerba Pharmaceuticals, Inc.

Relationship likelihood: Strong

Partner at 1315 Capital LLC

Relationship likelihood: Strong

Managing Director at Cowen Healthcare Royalty Management LLC

Relationship likelihood: Strong

Principal at Healthcare Royalty Management LLC

Relationship likelihood: Strong

Former Associate Director at Pfizer, Inc.

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Ocugen, Inc.

Relationship likelihood: Strong

Paths to Warren D. Cooper
Potential Connections via
Relationship Science
You
Warren D. Cooper
Partner & Chief Medical Officer at Healthcare Royalty Management LLC
Education
Undergraduate Degree
Class of 1977

The University of London is a collegiate research university located in London, England, consisting of 18 constituent colleges, 10 research institutes and a number of central bodies. The nine largest institutions of the federal university, usually termed the colleges, are Birkbeck, Goldsmiths, King's College London, the London Business School, Queen Mary, Royal Holloway, SOAS, LSE and UCL. Formerly a constituent college, Imperial College London left the University of London in 2007.

Memberships
Member
Current

THE MISSION OF THE AMERICAN SOCIETY OF HYPERTENSION, INC. (ASH) IS TO PROMOTE STRATEGIES TO PREVENT HYPERTENSION AND TO IMPROVE THE CARE OF PATIENTS WITH HYPERTENSION AND ASSOCIATE DISORDERS.

Career History
Partner & Chief Medical Officer
2017 - Current

Healthcare Royalty Management invests primarily in commercial stage healthcare companies, pharmaceutical, biotechnology and products through the purchase of traditional passive royalties, the creation of synthetic royalties, structured debt and equity instruments. The firm focus on healthcare companies and products across a broad range of therapeutic areas predominately in the US and European Union. They targets investments of $20 million to $200 million. They provides financing capital to assist in the transfer of product and execution risk, finance new development opportunities, acquire new products or technologies, fund additional capital needs and monetize product royalties.

Interim President & Chief Executive Officer
2013 - 2014

Nuron Biotech, Inc. markets and develops vaccines for the prevention and treatment of infectious diseases. It develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. The firm is advancing products to meet unmet medical needs in the areas of multiple sclerosis, alzheimer's, hepatitis b and hepatitis c for patients across the globe. The company was founded by Vithalbhai Dhaduk, Shankar Musunuri and David Zeng in 2009 and is headquartered in Exton, PA.

President & Chief Executive Officer
2004 - 2011

Prism Pharmaceuticals, Inc. manufactures cardiovascular injectables and pharmaceutical products. The firm engages in developing and commercializing branded cardiovascular injectable products which include NEXTERONE. The company was founded by Gilbert R. Gonzales and Cameron Durrant in 2003 and is headquartered in King of Prussia, PA.

Boards & Committees
Director
Prior - 2015

Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland.

President, Chief Executive Officer & Director
2013 - 2014

Nuron Biotech, Inc. markets and develops vaccines for the prevention and treatment of infectious diseases. It develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. The firm is advancing products to meet unmet medical needs in the areas of multiple sclerosis, alzheimer's, hepatitis b and hepatitis c for patients across the globe. The company was founded by Vithalbhai Dhaduk, Shankar Musunuri and David Zeng in 2009 and is headquartered in Exton, PA.

Independent Director
2002 - Prior

NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY.

Director
2010 - Prior

The World Affairs Council of Philadelphia is a private, nonprofit, nonpartisan educational organization dedicated to informing and engaging people of all ages on matters of national and international significance. The Council provides its members and the greater Philadelphia community with access to influential figures in the global area as well as opportunities to visit fascinating destinations through its unique travel program. With the support of individual and corporate members, the Council’s global education program enhances the education of area students who are the citizens, workforce and leaders of the future. Established in 1949 as a forum for discussing differing points of view, the Council does not endorse candidates for public office or lobby for policies. Membership is open to all who share its principles. We currently serve more than 75 corporate members and their executives, and nearly 2,000 individual members.

Transactions
Details Hidden

Nuron Biotech, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Warren D. Cooper. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Warren D. Cooper's profile does not indicate a business or promotional relationship of any kind between RelSci and Warren D. Cooper.